Total Payments
$4,865
2024 Payments
$1,604
Companies
25
Transactions
188
Medicare Patients
3,658
Medicare Billing
$678,552
Payment Breakdown by Category
Food & Beverage$4,703 (96.7%)
Education$161.78 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,703 | 177 | 96.7% |
| Education | $161.78 | 11 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,121 | 36 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $704.89 | 34 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $592.68 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $389.36 | 14 | $0 (2024) |
| Travere Therapeutics, Inc. | $315.00 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $186.44 | 11 | $0 (2024) |
| Relypsa, Inc. | $179.41 | 6 | $0 (2020) |
| Fresenius USA Marketing, Inc. | $175.82 | 3 | $0 (2022) |
| OPKO Pharmaceuticals, LLC | $169.97 | 8 | $0 (2023) |
| SHIELD THERAPEUTICS INC | $149.72 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,604 | 73 | Bayer Healthcare Pharmaceuticals Inc. ($336.64) |
| 2023 | $1,327 | 53 | Otsuka America Pharmaceutical, Inc. ($318.39) |
| 2022 | $812.00 | 37 | AstraZeneca Pharmaceuticals LP ($330.33) |
| 2021 | $194.85 | 2 | AstraZeneca Pharmaceuticals LP ($194.85) |
| 2020 | $309.79 | 7 | Fresenius USA Marketing, Inc. ($161.00) |
| 2019 | $88.01 | 4 | Relypsa, Inc. ($60.31) |
| 2018 | $322.98 | 8 | E.R. Squibb & Sons, L.L.C. ($105.14) |
| 2017 | $206.14 | 4 | Relypsa, Inc. ($84.93) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: NEPHROLOGY | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $30.82 | General |
| 11/12/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $0.90 | General |
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: NEPHROLOGY | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 11/05/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $87.49 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: NEPHROLOGY | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $2.06 | General |
| Category: NEPHROLOGY | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Immunology | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: NEPHROLOGY | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Cardio-renal | ||||||
| 09/06/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $42.69 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 831 | 1,738 | $452,992 | $143,480 |
| 2022 | 13 | 912 | 2,895 | $537,120 | $189,042 |
| 2021 | 13 | 737 | 1,599 | $454,897 | $141,110 |
| 2020 | 14 | 1,178 | 2,296 | $540,757 | $204,919 |
Total Patients
3,658
Total Services
8,528
Medicare Billing
$678,552
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 208 | 734 | $142,533 | $44,659 | 31.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 21 | 86 | $71,333 | $22,929 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 253 | $69,152 | $22,041 | 31.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 24 | 80 | $54,486 | $17,709 | 32.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 148 | 165 | $51,200 | $16,450 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $15,324 | $4,630 | 30.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 50 | $14,480 | $4,591 | 31.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 28 | 57 | $11,514 | $3,086 | 26.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $9,180 | $2,676 | 29.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 36 | 52 | $5,874 | $1,969 | 33.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 109 | 180 | $3,876 | $1,505 | 38.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 18 | 20 | $4,040 | $1,234 | 30.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 264 | 1,174 | $180,713 | $64,035 | 35.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 99 | 415 | $95,679 | $32,896 | 34.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 142 | 175 | $50,729 | $18,311 | 36.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 110 | 116 | $53,052 | $17,366 | 32.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 21 | 66 | $30,250 | $15,073 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 153 | $44,676 | $14,445 | 32.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 11 | 33 | $20,637 | $9,141 | 44.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $22,098 | $6,081 | 27.5% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 31 | 34 | $10,042 | $3,487 | 34.7% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 18 | 538 | $13,143 | $2,889 | 22.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 44 | 85 | $7,795 | $2,541 | 32.6% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 19 | 37 | $6,105 | $2,036 | 33.4% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 11 | 11 | $2,200 | $740.38 | 33.7% |
About Dr. Ahmad Eter, MD
Dr. Ahmad Eter, MD is a Hospitalist healthcare provider based in Beckley, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1003127432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ahmad Eter, MD has received a total of $4,865 in payments from pharmaceutical and medical device companies, with $1,604 received in 2024. These payments were reported across 188 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,703).
As a Medicare-enrolled provider, Eter has provided services to 3,658 Medicare beneficiaries, totaling 8,528 services with total Medicare billing of $678,552. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Nephrology
- Location Beckley, WV
- Active Since 06/30/2010
- Last Updated 01/06/2022
- Taxonomy Code 208M00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003127432
Products in Payments
- Kerendia (Drug) $704.89
- LOKELMA (Drug) $637.23
- JYNARQUE (Drug) $628.60
- FARXIGA (Drug) $437.64
- JARDIANCE (Drug) $389.36
- Veltassa (Drug) $224.51
- RAYALDEE (Drug) $169.97
- ELIQUIS (Drug) $165.96
- ACCRUFER (Drug) $149.72
- LIBERTY SELECT CYCLER (Device) $92.58
- XARELTO (Drug) $77.74
- Wegovy (Drug) $73.25
- Fabhalta (Drug) $71.56
- BENLYSTA (Biological) $66.12
- Horizant (Drug) $58.86
- Ozempic (Drug) $58.55
- MOVANTIK (Drug) $46.59
- Axonics (Device) $31.89
- GIVLAARI (Drug) $28.53
- ENTRESTO (Drug) $25.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.